Gabriel Alejandro Valiente Feruglio is a Professor at the Universitat Politècnica de Catalunya (UPC), affiliated with the Barcelona School of Informatics (FIB) and the Department of Computer Science. He is a member of the ALBCOM research group, focusing on Algorithms, Bioinformatics, Complexity, and Formal Methods. His work integrates theoretical computer science with applications in computational biology, including phylogenetic analysis, graph algorithms, and metagenomics. Valiente’s research emphasizes the development of algorithms for biological networks, phylogenetic tree and network comparison, and efficient graph representation. He has contributed to tools like TANGO for taxonomic assignment in metagenomics and AligNet for protein-protein interaction network alignment. His publications span over 140 works in journals like BMC Bioinformatics, IEEE-ACM Transactions on Computational Biology, and Bioinformatics. He leads and collaborates in competitive research projects funded by institutions like the Catalan government, focusing on bioinformatics, computational biology, and algorithmic methods. His research also extends to LaTeX typesetting for scientific documents and the structural analysis of scientific collaborations in graph transformations.
Samuli Ripatti is a Professor of Biometry in the Department of Public Health at the University of Helsinki's Faculty of Medicine. He serves as Director of the Institute for Molecular Medicine Finland (FIMM) since 2023 and leads the Academy of Finland's Center of Excellence in Complex Disease Genetics. His research integrates genetics, statistics, and clinical medicine to advance understanding of cardiometabolic diseases and genomic risk prediction. Education: Statistics major, University of Helsinki PhD in Mathematical Statistics, Stockholm University (2002) Docent in Statistics, University of Helsinki (2007) Research interests focus on cardiometabolic diseases, polygenic risk scores (PRS), and genetic epidemiology. He has pioneered PRS for disease prevention and developed clinical risk algorithms, with applications in precision medicine and global health initiatives. Recent publications highlight trends in polygenic risk modeling across diverse diseases, lipidomics, sleep disorders, and trauma outcomes. His work spans genomics, bioinformatics, and translational medicine. Scientific awards: Knight, First Class, of the Order of the White Rose of Finland (2021) Highly Cited Researcher (2018, 2017, 2016) Ripatti chairs doctoral programs in life sciences and the EU-funded INTERVENE project, which develops genomic risk prediction methods. He has led research groups at FIMM-EMBL, the Broad Institute, and the Wellcome Trust Sanger Institute. As Director of FIMM and member of scientific advisory boards (e.g., NMRC Singapore, EXCEED), he shapes global genomic research collaborations and biobank infrastructure.
Ankur Agrawal is the Chair and Professor of Computer Science at St. Edward's University, School of Natural Sciences. His research focuses on Biomedical Informatics with an emphasis on ontology engineering and quality assurance of healthcare terminologies like SNOMED CT. Dr. Agrawal also serves as CAC Commissioner and Team Chair at ABET, demonstrating leadership in accreditation and educational standards. His work centers on improving healthcare data systems through machine learning applications, lexical analysis, and structural consistency checks in biomedical ontologies. Key contributions include developing tools for crowd-sourced ontology curation and visualizing SNOMED CT hierarchies. Publications from 2013-2024 consistently address quality assurance challenges in healthcare terminologies, leveraging both algorithmic and contextual methods. No scholarly awards are explicitly mentioned in the provided texts. Advising and grants: No specific student advisees or grant details provided in the text. His professional roles extend beyond academia to ABET, where he contributes to accreditation processes for engineering and technology programs. Labs/teams: Involved with ABET's accreditation committees and maintains a research focus through BioPortal and SNOMED CT initiatives.
Eric W. Klee, Ph.D., is a Professor of Biomedical Informatics at Mayo Clinic, leading translational research in omics data integration and precision medicine. He holds key roles including Scientific Director of Research Data and Digital Innovation, Enterprise Co-Leader of Cancer Informatics & Data Science at the Mayo Clinic Comprehensive Cancer Center, and Director of Digital Omics in the Center for Individualized Medicine. His work focuses on rare disease diagnosis, genomic data infrastructure, and machine learning applications in healthcare. Education: Ph.D. in Health Informatics, University of Minnesota MS in Health Informatics, University of Minnesota BS in Electrical Engineering, Iowa State University Research Interests: Dr. Klee’s research integrates multi-omics profiling, AI-driven analytics, and cloud-based platforms to advance diagnostics and treatment for rare genetic disorders. He leads initiatives like RADIaNT (RNA sequencing for rare diseases), SAVI (automated variant interpretation), and RENEW (continuous genomic data reanalysis). His work bridges lab discoveries with clinical practice, emphasizing precision medicine and scalable genomic solutions. Publications Trends: His recent work highlights RNA-based diagnostics, AI in variant prioritization, and infrastructure for population-level genomic screening. Key areas include drug repositioning for tobacco dependence and molecular mechanisms of Mendelian diseases. Awards: Research Award from the Minnesota Partnership for Biotechnology and Medical Genomics (2023) Advising & Grants: Leads the Mayo Clinic’s Digital Omics initiative and co-leads cancer informatics efforts. His lab collaborates on NIH-funded studies and industry partnerships to translate genomic insights into clinical tools. Labs/Teams: Directs the Advanced Diagnostics Laboratory’s bioinformatics team and chairs the Undiagnosed Diseases Network International board, fostering global rare disease research collaboration.
Claire Robin is a university lecturer and hospital practitioner affiliated with the Faculty of Pharmacy at Université Clermont Auvergne (UCA). She is part of the Department of Biology at CHU G. Montpied in Clermont-Ferrand. Her academic rank is Lecturer. Her research focuses on antibiotic resistance, plasmids, and virulence, with teaching responsibilities in clinical bacteriology, bacteriology-virology, and hospital hygiene. Her research contributions include studies on microbial genomics in aquatic environments, antibiotic resistance mechanisms in hospital settings, and clinical pathogenesis of infections. Notable publications include work on Sulfurimonas clades in ferruginous lakes, freshwater microbiome databases, and catheter-associated bacteriuria in critical care patients. No awards or grants are explicitly mentioned. She is currently active as permanent staff at UCA, with no indication of part-time status or retirement.
Prof Benjamin Schwessinger is a Professor at the Australian National University (ANU), affiliated with the Division of Plant Sciences. His research focuses on plant pathogens, fungal genomics, and the evolutionary dynamics of pathogen adaptation. Key areas include understanding rust fungi biology, host-pathogen interactions, and structural genomic variations in plants like Eucalyptus. He has pioneered methodologies for high-throughput protein secretion optimization in yeast and developed diagnostic tools for invasive pathogens such as Austropuccinia psidii (myrtle rust). Research Interests: Plant-microbe interactions and immunity Fungal genomics and sexual recombination mechanisms Evolving pathogen populations in agricultural systems Genomic tools for disease surveillance and biosecurity His recent work explores the genomic basis of pathogen adaptation, including studies on wheat stripe rust and myrtle rust. Collaborations span fungal pathogenomics, eucalyptus structural genomics, and yeast biotechnology. He leads multiple projects funded by ANU and ARC, including the Plant Biosecurity Training Centre. His lab emphasizes reproducible research practices and early career researcher development. Key projects include: Digital yeast bioprospecting for non-alcoholic beer production Surveillance of airborne pathogens in Australian Botanic Gardens Genome evolution of cereal rust fungi Labs/Teams: Core member of ANU's Plant Biosecurity Group and collaborator in the ARC Training Centre in Plant Biosecurity.
Aviv Bergman is a Professor at Albert Einstein College of Medicine, holding appointments in the Department of Systems & Computational Biology, Department of Pathology, and Dominick P. Purpura Department of Neuroscience. He is also Founding Chairman of the Department of Systems & Computational Biology and Director of the Albert Einstein Institute for Advanced Study in the Life Sciences. His research integrates computational, mathematical, and experimental approaches with philosophical frameworks (phenomenology, hermeneutics, pragmatism) to study evolutionary and developmental systems biology, focusing on complex traits, biological networks, and the interplay between function, organization, and agency in living systems. Prior publications highlight his work on evolutionary capacitance, gene network topology, developmental canalization, and genome-wide amino acid patterns. He emphasizes iterative refinement of theoretical models through empirical data validation.
Aurora Martinez is a Professor in the Department of Biomedicine at the University of Bergen, Faculty of Medicine. She leads the Biorecognition research group, focusing on the structural and functional aspects of biomolecules in neurometabolic disorders such as phenylketonuria (PKU) and dopamine synthesis defects. She is also a partner in the KG Jebsen Centre for Neuropsychiatric Disorders and a Toppforsk-funded project on the Arc protein, a master regulator of synaptic plasticity. Position: Professor Institution: University of Bergen Department: Department of Biomedicine Research Group: Biorecognition Email: aurora.martinez@uib.no Her research integrates structural biology, molecular recognition, and drug discovery to develop therapeutic strategies for genetic and neurodegenerative diseases. Key areas include tyrosine hydroxylase regulation, mitochondrial dysfunction in dopaminergic cells, and neurotransmitter transport mechanisms. She employs biochemical, cellular, and computational approaches to understand disease mechanisms and identify novel therapeutics. The recent publications (2023–2025) reflect a strong trend toward understanding dopamine-related pathways, protein stabilization, and therapeutic interventions in Parkinsonism and related disorders. Themes include chaperone-mediated protein stabilization, high-throughput screening for VMAT2 modulators, and computational tools for drug discovery. The work combines experimental validation with translational applications in neurodegenerative models. She has supervised multiple Master’s students, including Md. Ekhtear Mahmud, Sofie Breisnes Wormdahl, and Kristine Kippersund Brokstad, indicating active mentorship and training roles. Her involvement in large-scale collaborative projects highlights leadership and interdisciplinary engagement. While no specific awards are listed, her participation in prestigious programs like Toppforsk and the KG Jebsen Centre underscores recognition and funding success. She has no listed grants explicitly, but project affiliations suggest competitive funding support. Her research group maintains strong technical capabilities in protein analysis, cellular screening, and structural modeling. The Martinez Lab is actively involved in both fundamental and applied research, with future directions likely to expand into gene therapy, precision medicine for metabolic disorders, and neuroprotective strategies.
Miquel Moreto Planas is a Senior Lecturer in the Department of Computer Architecture at the Barcelona School of Informatics, Universitat Politècnica de Catalunya (UPC). He is also affiliated with the Barcelona Supercomputing Center (BSC-CNS), a leading institution in high-performance computing. His academic profile is deeply rooted in computer architecture and high-performance computing, with a strong emphasis on practical and theoretical advancements in multicore systems, memory management, and hardware acceleration. His research interests span a wide range of topics including computer architecture, high-performance computing, multicore and manycore systems, cache and memory management, hardware acceleration for genomics and AI, RISC-V processor design, processing-in-memory, interconnection networks, and real-time systems. These interests are reflected in his extensive publication record and collaborative projects. The most recent articles highlight a significant trend toward interdisciplinary research, particularly the application of advanced computer architecture techniques to bioinformatics and healthcare. Key themes include the acceleration of genomic sequence alignment using novel hardware such as processing-in-memory, the development of benchmarks for ARM-based HPC systems in genomics, and the creation of AI-based 3D decision support tools for neurosurgical applications. His work also continues to advance core computer architecture topics like cache management, power-aware resource allocation in heterogeneous systems, and the design of secure, post-quantum cryptographic hardware based on RISC-V. Fulbright Award 2011 HiPEAC Paper Award HiPEAC Paper Award 2024 HiPEAC Paper Award Moreto has been a principal investigator or key contributor to multiple competitive R&D+i projects, such as the STRATUM project for neurosurgical tools, REDIOH for open hardware, and the Laboratorio Zettaescala de Barcelona. He has advised several doctoral students, including López, G., Kostalampros, I., and Haghi, A., and is a core member of the CAP (High Performance Computing) research group at UPC. His work is characterized by strong collaborations with leading researchers like Mateo Valero, Eduard Ayguadé, and Jesús Labarta, often bridging the gap between UPC and BSC-CNS. His laboratory and team affiliations are centered around the CAP group and the Barcelona Supercomputing Center, where he contributes to cutting-edge research in high-performance and embedded computer architectures. His recent work on the BIMSA accelerator and the STRATUM project demonstrates a clear future direction toward applying high-performance computing solutions to critical problems in genomics and medicine.
Prof. Mile Šikić is a Full Professor at the Department of Electronic Systems and Information Processing, Faculty of Electrical Engineering and Computing (University of Zagreb). His research spans computational biology, genomics, and machine learning applications in sequencing technologies. Focus on nanopore sequencing analysis, genome assembly, and protein interaction prediction Developed tools like GraphMap , RiNALMo , and Orthobalancer Active in metagenomics, RNA structure prediction, and CUDA-based algorithm acceleration Scientific contributions include: Advances in de novo genome assembly for error-prone long reads Deep learning models for base modification detection Efficient algorithms for sequence alignment and similarity searches Technical implementations cover: GPU-accelerated sequence alignment libraries (e.g., SW# ) Web platforms for comparative protein analysis Simulation tools for epidemic spread on complex networks
Katelyn Byrne is an Assistant Professor at Oregon Health and Science University (OHSU) in the Cell, Developmental and Cancer Biology department, affiliated with the Knight Cancer Institute and Brenden-Colson Center for Pancreatic Care. Her research focuses on the immunobiology of pancreatic cancer, particularly mechanisms bridging innate and adaptive immunity to enhance immunotherapy efficacy. Education: B.A. (2007) from Boston University, Ph.D. (2013) from Dartmouth College, and postdoctoral training as a Senior Parker Fellow. Her work leverages genetically engineered mouse models of pancreatic cancer to study tumor microenvironment dynamics , with clinical translation in immunotherapy trials. Key contributions include CD40 agonism for CD4+ T cell-mediated tumor rejection, immune checkpoint blockade synergy, and spatial transcriptomics for infiltrate heterogeneity. Recent articles (2024) highlight machine learning in immune profiling and MHC class I-deficient tumor targeting. Dr. Byrne is a recipient of the American Cancer Society Post-doctoral Fellowship and Senior Parker Fellowship . She mentors graduate students Margaret Haerr and Yi Zhang in her lab, which collaborates across OHSU’s cancer research centers. Current projects aim to develop novel immunotherapy combinations and T cell infiltration strategies for pancreatic cancer.
Raşit Bilgin is an Associate Professor at the Institute of Environmental Sciences, Boğaziçi University, Istanbul, where he has been serving since 2012. He previously held positions as Assistant Professor (2008–2012) and Instructor (2007–2008) at the same institute. His academic leadership includes serving as the Chair of the Department of Environmental Sciences. Education: Ph.D., Department of Ecology, Evolution and Environmental Biology, Columbia University, USA (2006) M.Phil., Department of Ecology, Evolution and Environmental Biology, Columbia University, USA (2003) M.A., Department of Ecology, Evolution and Environmental Biology, Columbia University, USA (2002) M.S., Institute of Environmental Sciences, Boğaziçi University, Turkey (2000) B.S., Civil Engineering Department, Boğaziçi University, Turkey (1998) His research lies at the intersection of molecular ecology, evolutionary biology, and conservation genetics, with a strong focus on environmental DNA and phylogeography. He investigates genetic patterns in marine and terrestrial species, particularly in Anatolia and the Mediterranean, aiming to understand biodiversity dynamics and inform conservation strategies. His work often integrates genomic tools with ecological modeling to explore population history and species resilience. The recent publications highlight a consistent trend in using molecular markers—especially mitochondrial and nuclear DNA—to study population structure, historical demography, and species distribution. His research spans marine crustaceans, bats, and broader biodiversity assessments, reflecting a multidisciplinary approach combining field ecology, genomics, and computational tools. Scientific Awards: No specific awards mentioned in the provided text. Raşit Bilgin has been actively involved in research funding and project leadership, including TÜBİTAK 1001 and 2501 projects, as well as internal Boğaziçi University grants. These projects focus on conservation genomics of seabirds, coral disease resistance, and Antarctic amphipods. While direct student advising is not explicitly listed, his leadership in research projects suggests mentorship of graduate students. He has developed analytical tools like Kgtests, indicating a contribution to methodological advancements in population genetics. He leads research initiatives involving multi-omics, acoustic monitoring, and GPS-GSM tracking, suggesting an interdisciplinary lab environment focused on innovative conservation technologies. His team likely includes researchers working on genomics, bioinformatics, and field ecology, particularly in extreme environments such as the Antarctic and Mediterranean ecosystems.
Bin Tian, Ph.D., is a Professor in the Department of Biochemistry and Biophysics at The Wistar Institute and serves as Program Co-Leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center. He is also the Director of the Center for Systems & Computational Biology. His research integrates molecular biology, computational genomics, and functional studies to understand RNA processing, particularly alternative polyadenylation (APA), and its roles in cancer and immunity. His educational background includes a B.S. in Biochemistry from East China University of Science and Technology and a Ph.D. in Molecular Biology from Rutgers Biomedical and Health Sciences (formerly UMDNJ). He completed postdoctoral training in bioinformatics and genomics at Johnson & Johnson before establishing his independent lab at Rutgers New Jersey Medical School in 2003, where he became a tenured professor in 2014. He joined The Wistar Institute in 2020. His research focuses on molecular systems biology of RNA, including functional genomics of cleavage and polyadenylation, regulation of gene expression through early transcriptional termination, spatial and temporal control of mRNA metabolism via alternative 3’UTRs, and cleavage and polyadenylation inhibition (CPAi) as a cancer therapeutic strategy. His lab has developed key bioinformatics resources like PolyA_DB, APAlyzer, and MAAPER. His recent publications show a strong trend in dissecting APA mechanisms across physiological and pathological contexts, including cancer, neuronal function, and immune cell differentiation. The work combines high-throughput sequencing, single-cell analysis, and computational modeling to uncover how APA regulates mRNA stability, localization, and function. He mentors a team of postdoctoral fellows, predocotoral trainees, and research assistants, contributing to training the next generation of scientists. His lab is actively pursuing novel therapeutics targeting mRNA 3’ end processing in cancer and immune disorders.
Chambers C. Hughes is a Research Group Leader in the Department of Microbial Bioactive Compounds at the University of Tübingen, Germany. Previously, he held positions as an Assistant Professor at the Scripps Institution of Oceanography (2012–2019) and a postdoctoral researcher with Prof. William Fenical (2005–2012). His research focuses on microbial natural product discovery, synthesis, and chemical biology, particularly employing reactivity-guided isolation and bioactivity-guided approaches to uncover novel bioactive compounds. His group has pioneered methods using chemoselective probes to target metabolites with specific functional groups, enabling the discovery of siderophores, antibiotics, and other secondary metabolites. Education: B.S. in Biochemistry, Geneseo College (1999) Ph.D. in Chemistry, University of California, Berkeley (2004) Research Interests: The Hughes Group explores microbial natural products using cutting-edge techniques like NMR spectroscopy and mass spectrometry. They focus on marine and terrestrial organisms, emphasizing the development of chemical labeling strategies to identify electrophilic compounds (e.g., epoxides, β-lactams) and conjugated alkenes. Their work bridges synthetic chemistry and biological activity, targeting antibiotic discovery, enzyme inhibition, and metabolic pathway elucidation. Notable Contributions: The group has characterized marinopyrroles (protonophoric antibiotics), kasichelins (siderophores), and vatiamides (polyketide natural products). Their methods have revealed artifacts in previously reported natural products and enabled genome-mining approaches to de-orphan biosynthetic gene clusters. Students & Collaborations: Current students include Shu-Ning Xia, Sehee Jang, Luca Salvi, and Max Knab. Collaborations span microbiology, synthetic chemistry, and bioinformatics, with key partners at the University of Tübingen and Scripps Oceanography. Labs & Facilities: The Hughes Research Group operates within the Interfaculty Institute of Microbiology and Infection Medicine, leveraging advanced analytical tools for natural product characterization and synthesis.
Donald E. Brown is the W.S. Calcott Professor in the Systems and Information Engineering Department at the University of Virginia, serving as Founding Director of the Data Science Institute and Co-Director of the Translational Health Institute of Virginia. He holds a B.S. from the United States Military Academy (1973), M.S. and M.E. from UC Berkeley (1979), and a Ph.D. from the University of Michigan (1985). His research focuses on data fusion, knowledge discovery, and predictive modeling with applications in healthcare, security, and safety. Dr. Brown leads over 90 federal/state/private research projects, publishes extensively (120+ papers, 2 books), and is a Fellow of the IEEE. He has received prestigious awards including the Norbert Wiener Award and IEEE Millennium Medal. His work bridges academia and industry through Commonwealth Computer Research, Inc., providing data analysis services. He advises on national committees including the National Research Council and the NRC Committee on Transportation Security. His teaching excellence was recognized by students three times as 'best undergraduate teacher' (2001–2003). Research Interests: Data Fusion, Knowledge Discovery, Simulation Optimization, Machine Learning, Predictive Analytics Publications: Focus on healthcare analytics (e.g., Long COVID, tuberculosis, histopathology), AI-driven medical imaging (capsule endoscopy, eosinophil segmentation), and cybersecurity applications. Awards: IEEE Joseph Wohl Career Achievement Award (2017), Governor's Technology Award (1999), Norbert Wiener Award (2002). Grants/Projects: Over 90 funded projects on data science, healthcare tech, and security systems. He leads interdisciplinary initiatives like the iTHRIV Commons for health data sharing and develops AI tools for medical diagnostics at UVA. Current work includes AI in cardiovascular disease prediction, perioperative data digitization for LMICs, and real-time anomaly detection in healthcare systems.
